Monitoring hand, foot and mouth disease in children
Official title: Prospective Clinico-virological Surveillance of Diseases Foot-hand-mouth/Herpangina Associated With Enteroviruses in Pediatric Outpatients
Run by University Hospital, Clermont-Ferrand · NCT06263439 · Data updated 2026-11-12
This study is trying to find out which types of viruses cause hand, foot, and mouth disease in kids by collecting samples from children with symptoms to help track outbreaks.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 10 Years |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 1 site (Clermont-Ferrand) |
| Status | Recruiting |
| Started | June 20, 2023 |
| Main results expected | June 20, 2028 |
| Study ends | June 20, 2028 |
| Registry record updated | February 16, 2024 |
| Trial ID | NCT06263439 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 0 to 10 years who show signs of hand, foot and mouth disease or herpangina.
✕Probably not a fit
Patients who refuse to participate or are older than 10 years may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify the types of enteroviruses responsible for hand, foot and mouth disease (HFMD) and herpangina in pediatric outpatients. Children aged 0 to 10 years presenting with symptoms suggestive of these conditions will have throat or mouth swabs collected by pediatricians. The samples will be sent to a national reference laboratory for enterovirus detection and genotyping, while demographic and clinical data will also be gathered during the consultation. The study seeks to detect potential epidemics and compare the characteristics of different enterovirus types.
Why it matters
Potential benefit: If successful, this study could enhance early detection and management of enterovirus infections in children.
How similar studies have gone: Other studies have successfully monitored enterovirus infections, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged 0 to 10 years presenting with HFMD or herpangina Exclusion Criteria: * Refusal to participate by holders of parental authority * Refusal to participate for children over 3 years of age
Where it's running
-
CHU de Clermont-Ferrand
Clermont-Ferrand, France Recruiting
Study contacts
- Principal investigator: Audrey MIRAND — University Hospital, Clermont-Ferrand
- Study coordinator: Lise LACLAUTRE
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: +33473754963
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using AI to train doctors in pediatric care
This study is testing whether using virtual patients powered by AI can help train doctors in China to better care for children with common health issues.
-
Evaluating a new vaccine for Hand, Foot, and Mouth Disease in young children
This study is testing a new vaccine to see if it can help protect young children from Hand, Foot, and Mouth Disease.
-
Community spread of multiple infectious diseases in Cambodia from a One Health perspective
This project will test how common and connected dengue, chikungunya, Zika, Japanese encephalitis, and West Nile infections are among people, animals, and the environment across Cambodia.
-
Neonatal Echovirus 11 infections in Italy: virological, genomic and clinical insights
This project will test whether sequencing virus samples from newborns with enterovirus infections, especially Echovirus 11, helps explain how the virus causes illness in the first weeks of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.